title: Conservation and variability of dengue virus proteins: implications for vaccine design.
abstract: BACKGROUND
  Genetic variation and rapid evolution are hallmarks of RNA viruses, the result of high mutation rates in RNA replication and selection of mutants that enhance viral adaptation, including the escape from host immune responses. Variability is uneven across the genome because mutations resulting in a deleterious effect on viral fitness are restricted. RNA viruses are thus marked by protein sites permissive to multiple mutations and sites critical to viral structure-function that are evolutionarily robust and highly conserved. Identification and characterization of the historical dynamics of the conserved sites have relevance to multiple applications, including potential targets for diagnosis, and prophylactic and therapeutic purposes.
  
  
  RESULTS
  We describe a large-scale identification and analysis of evolutionarily highly conserved amino acid sequences of the entire dengue virus (DENV) proteome, with a focus on sequences of 9 amino acids or more, and thus immune-relevant as potential T-cell determinants. DENV protein sequence data were collected from the NCBI Entrez protein database in 2005 (9,512 sequences) and again in 2007 (12,404 sequences). Forty-four (44) sequences (pan-DENV sequences), mainly those of nonstructural proteins and representing approximately 15% of the DENV polyprotein length, were identical in 80% or more of all recorded DENV sequences. Of these 44 sequences, 34 ( approximately 77%) were present in >or=95% of sequences of each DENV type, and 27 ( approximately 61%) were conserved in other Flaviviruses. The frequencies of variants of the pan-DENV sequences were low (0 to approximately 5%), as compared to variant frequencies of approximately 60 to approximately 85% in the non pan-DENV sequence regions. We further showed that the majority of the conserved sequences were immunologically relevant: 34 contained numerous predicted human leukocyte antigen (HLA) supertype-restricted peptide sequences, and 26 contained T-cell determinants identified by studies with HLA-transgenic mice and/or reported to be immunogenic in humans.
  
  
  CONCLUSIONS
  Forty-four (44) pan-DENV sequences of at least 9 amino acids were highly conserved and identical in 80% or more of all recorded DENV sequences, and the majority were found to be immune-relevant by their correspondence to known or putative HLA-restricted T-cell determinants. The conservation of these sequences through the entire recorded DENV genetic history supports their possible value for diagnosis, prophylactic and/or therapeutic applications. The combination of bioinformatics and experimental approaches applied herein provides a framework for large-scale and systematic analysis of conserved and variable sequences of other pathogens, in particular, for rapidly mutating viruses, such as influenza A virus and HIV.
authors.affiliation: Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
authors.forename: Asif M
authors.initials: AM
authors.lastname: Khan
authors.forename: Olivo
authors.initials: O
authors.lastname: Miotto
authors.forename: Eduardo J M
authors.initials: EJ
authors.lastname: Nascimento
authors.forename: K N
authors.initials: KN
authors.lastname: Srinivasan
authors.forename: A T
authors.initials: AT
authors.lastname: Heiny
authors.forename: Guang Lan
authors.initials: GL
authors.lastname: Zhang
authors.forename: E T
authors.initials: ET
authors.lastname: Marques
authors.forename: Tin Wee
authors.initials: TW
authors.lastname: Tan
authors.forename: Vladimir
authors.initials: V
authors.lastname: Brusic
authors.forename: Jerome
authors.initials: J
authors.lastname: Salmon
authors.forename: J Thomas
authors.initials: JT
authors.lastname: August
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D003716:Dengue Virus / Q000276:immunology* / Q000378:metabolism*; D006684:HLA-DR Antigens / Q000235:genetics / Q000276:immunology; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D014764:Viral Proteins / Q000737:chemistry* / Q000276:immunology*; D014765:Viral Vaccines / Q000737:chemistry* / Q000276:immunology*
chemical_list: D006684:HLA-DR Antigens; D014764:Viral Proteins; D014765:Viral Vaccines